We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Honda
HMC
$41.7B
| $6.29M | 0.02% |
+245,894
| New | +$5.98M |
|
652
Astronics
ATRO
$2.85B
| $6.26M | 0.02% |
711,438
+706,080
| +13,178% | +$5.52M |
|
653
XP
XP
$10B
| $6.21M | 0.02% |
147,947
+122,521
| +482% | +$3.76M |
|
|
PRFT
654
DELISTED
Perficient Inc
PRFT
| $6.21M | 0.02% |
173,641
-536,184
| -76% | -$17.8M |
|
655
VF Corp
VFC
$5B
| $6.21M | 0.02% |
101,859
-11,900
| -10% | -$693K |
|
656
Telefônica Brasil
VIV
$18.9B
| $6.2M | 0.02% |
699,592
-12,440
| -2% | -$113K |
|
657
Koppers
KOP
$884M
| $6.2M | 0.02% |
328,960
-99,765
| -23% | -$1.52M |
|
658
Tractor Supply
TSCO
$17.1B
| $6.19M | 0.02% |
234,890
+145,235
| +162% | +$3.18M |
|
659
Installed Building Products
IBP
$5.3B
| $6.19M | 0.02% |
89,971
-43,240
| -32% | -$2.4M |
|
660
Sabra Healthcare REIT
SBRA
$5.13B
| $6.14M | 0.02% |
425,270
+295,567
| +228% | +$3.89M |
|
661
Microchip Technology
MCHP
$37.8B
| $6.12M | 0.02% |
116,308
+34,226
| +42% | +$1.54M |
|
662
Independence Realty Trust
IRT
$3.52B
| $6.09M | 0.02% |
529,903
-68,802
| -11% | -$686K |
|
663
Ironwood Pharmaceuticals
IRWD
$689M
| $6.08M | 0.02% |
588,717
+6,547
| +1% | +$67K |
|
664
AAR Corp
AIR
$4.72B
| $6.07M | 0.02% |
293,729
+188,693
| +180% | +$3.65M |
|
665
EverQuote
EVER
$822M
| $6.04M | 0.02% |
103,881
+26,576
| +34% | +$1.25M |
|
666
Pool Corp
POOL
$6.1B
| $6.02M | 0.01% |
22,152
-1,368
| -6% | -$317K |
|
667
Thor Industries
THO
$3.63B
| $6.02M | 0.01% |
56,526
-20,685
| -27% | -$1.62M |
|
668
Cirrus Logic
CRUS
$5.91B
| $5.99M | 0.01% |
96,972
-94,031
| -49% | -$6.43M |
|
669
Neurocrine Biosciences
NBIX
$15.2B
| $5.97M | 0.01% |
48,932
+22,432
| +85% | +$2.48M |
|
670
Valero Energy
VLO
$116B
| $5.93M | 0.01% |
100,848
-49,684
| -33% | -$2.97M |
|
671
BorgWarner
BWA
$12.7B
| $5.92M | 0.01% |
190,538
+2,310
| +1% | +$60.8K |
|
672
Otis Worldwide
OTIS
$26.4B
| $5.92M | 0.01% |
+104,069
| New | +$5.39M |
|
673
SI-BONE Inc
SIBN
$831M
| $5.9M | 0.01% |
370,000
| – | – |
|
674
Starbucks
SBUX
$111B
| $5.89M | 0.01% |
80,002
-139,265
| -64% | -$10.5M |
|
675
CF Industries
CF
$20B
| $5.89M | 0.01% |
209,247
-299,202
| -59% | -$8.51M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.